Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease in presynaptic inhibition on heteronymous monosynaptic Ia terminals in patients with Parkinson's disease.

H Morita1, M Shindo, S Ikeda

  • 1The Third Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan.

Movement Disorders : Official Journal of the Movement Disorder Society
|September 29, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibition of aldosterone turn-off phenomenon following chronic adrenocorticotropin treatment with in vivo administration of antiglucocorticoid and antioxidants in rats.

European journal of endocrinology·1995
Same author

Relationship between susceptibility to apoptosis and Fas expression in peripheral blood T cells from uremic patients: a possible mechanism for lymphopenia in chronic renal failure.

Biochemical and biophysical research communications·1995
Same author

[Clinicopathological evaluation of etoposide or estramustine phosphate in castrated patients with advanced prostatic cancer].

Nihon Hinyokika Gakkai zasshi. The japanese journal of urology·1995
Same author

Two regions of GLUT 2 glucose transporter protein are responsible for its distinctive affinity for glucose.

Endocrinology·1995
Same author

Eucalyptone from Eucalyptus globulus.

Phytochemistry·1995
Same author

Studies on cognitive enhancing agents. II. Antiamnestic and antihypoxic activities of 1-aryl-2-(2-aminoethoxy)ethanols.

Chemical & pharmaceutical bulletin·1995
Same journal

Gene Therapy for Amino Acid Decarboxylase Deficiency: Clinical and Imaging Outcomes in a French Cohort.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Alzheimer's Disease Cerebrospinal Fluid Biomarkers Predict Survival in Progressive Supranuclear Palsy.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Hyperhomocysteinemia and Vitamin B Deficiency as Potential Aggravating Factors in Huntington's Disease: A Prospective Monocentric Study.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Longitudinal Dynamics of Polyglutamine-Expanded ATXN3 in Biofluids of Spinocerebellar Ataxia Type 3.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Putamen Structural-Functional Decoupling as an Early-Stage Candidate Imaging Marker for Motor Severity in Spinocerebellar Ataxia Type 3.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Melanopsin-Mediated Post-Illumination Pupillary Response in Idiopathic Rapid Eye Movement (REM) Sleep Behavior Disorder and Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026
See all related articles

Parkinson's disease patients exhibit reduced presynaptic inhibition (PSI), a key motor control mechanism. This decrease in PSI is linked to gait disturbances, suggesting a potential therapeutic target.

Area of Science:

  • Neuroscience
  • Motor Control
  • Clinical Neurology

Background:

  • Parkinson's disease (PD) is a neurodegenerative disorder affecting motor function.
  • Presynaptic inhibition (PSI) plays a crucial role in modulating spinal reflex excitability and central motor control.
  • Dysregulation of PSI has been implicated in various motor disorders.

Purpose of the Study:

  • To investigate heteronymous Ia facilitation, a measure of PSI, in individuals with Parkinson's disease.
  • To clarify the role of PSI in the central motor control deficits observed in PD.
  • To explore the relationship between PSI and motor symptoms like gait disturbance, bradykinesia, and rigidity.

Main Methods:

  • Quantified heteronymous Ia facilitation from quadriceps to soleus muscles.

Related Experiment Videos

  • Measured the extent of facilitation as the slope within 0.8 msec of onset, reflecting PSI.
  • Compared PSI levels between 17 PD patients and 36 age-matched controls.

    • Main Results:

    • Individuals with Parkinson's disease showed significantly greater heteronymous Ia facilitation compared to controls, indicating reduced PSI.
    • PSI was negatively correlated with walking speed in PD patients.
    • In a subset of patients, a decrease in PSI correlated with reduced bradykinesia but not rigidity.

    Conclusions:

    • The study suggests a decreased degree of PSI in Parkinson's disease.
    • Disturbances in the central control of PSI may contribute to gait disturbances in PD.
    • Targeting PSI could be a potential strategy for managing motor symptoms in Parkinson's disease.